Literature DB >> 9423212

The inherited basis of venous thrombosis.

R D Appleby1, R J Olds.   

Abstract

Venous thrombosis represents a manifestation of disordered hemostatic balance. The classical presentation is of pain and swelling of the lower limb, although clinical history and examination are notoriously misleading in reaching a diagnosis. A number of acquired predispositions have been associated with a tendency to thrombosis, such as immobilisation, surgery, malignancy and certain types of oral contraception, but in at least half of the instances no predisposition can be identified. A variety of genetic risk factors have also been identified. Mutations within the genes for antithrombin, protein C and protein S are associated with a venous thromboembolic phenotype. The commonest thrombophilic predisposition however is a variant of coagulation factor V, factor V Leiden, which results from a single amino acid substitution rendering the factor V molecule resistant to activated protein C. Factor V Leiden is present in approximately 5% of individuals of European origin, and is found in up to 40% of those with confirmed venous thrombosis. Increasingly it is recognised that venous thrombosis should be considered a polygenic disorder, with interactions between the various single gene defects which predispose to thrombosis, as well as normal genetic variation between individuals in the levels of both procoagulant and anticoagulant proteins, all determining which individuals will express the phenotype of venous thrombosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9423212     DOI: 10.1080/00313029700169285

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  5 in total

1.  Prevalence of methylenetetrahydrofolate reductase mutations in patients with venous thrombosis.

Authors:  P A Isotalo; J G Donnelly
Journal:  Mol Diagn       Date:  2000-03

2.  Genetic thrombophilia in patients with retinal vascular occlusion.

Authors:  K Greiner; D Peetz; A Winkgen; W Prellwitz; N Pfeiffer; G Hafner
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

3.  Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke.

Authors:  Z Szolnoki; F Somogyvári; A Kondacs; M Szabó; L Fodor; J Bene; B Melegh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

4.  Near real-time immuno-optical sensor for diagnosing single point mutation: a model system: sensor for factor V Leiden diagnosis.

Authors:  Kyung A Kang; Yongjie Ren; Vivek R Sharma; Stephen C Peiper
Journal:  Biosens Bioelectron       Date:  2009-02-20       Impact factor: 10.618

5.  Deep venous thrombosis following different isolated lower extremity fractures: what is known about prevalences, locations, risk factors and prophylaxis?

Authors:  S Decker; M J Weaver
Journal:  Eur J Trauma Emerg Surg       Date:  2013-02-21       Impact factor: 3.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.